Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma

• Published in: Scientific reports Vol. 7; no. 1; p. 40464
• Main Authors: Li, Xiao-Long, Liu, Lin, Li, Dan-Dan, He, Ya-Ping, Guo, Le-Hang, Sun, Li-Ping, Liu, Lin-Na, Xu, Hui-Xiong, Zhang, Xiao-Ping
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 13.01.2017; Nature Publishing Group
• Subjects: 13; 13/109; 42; 631/67; 64/60; 692/699/67; 82; 82/1; 82/29; 82/80; AKT protein; Animals; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - pathology; Cell proliferation; Cell Proliferation - genetics; Cell viability; Ectopic expression; Epithelial-Mesenchymal Transition - genetics; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Hep G2 Cells; Hepatocellular carcinoma; Humanities and Social Sciences; Humans; Immunocytochemistry; Integrin beta4 - metabolism; Invasiveness; Liver cancer; Liver Neoplasms - genetics; Liver Neoplasms - metabolism; Liver Neoplasms - pathology; Male; Mesenchyme; Metastases; Mice, Nude; Middle Aged; multidisciplinary; Neoplasm Invasiveness; Neoplasm Metastasis; Science; Snail Family Transcription Factors - metabolism; Therapeutic targets; Tissue analysis; Tumor Stem Cell Assay; Tumorigenesis; Tumors; Up-Regulation - genetics; Xenografts
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep40464

Integrin β4 (ITGB4) is a transmembrane receptor involved in tumorigenesis and the invasiveness of many cancers. However, its role in hepatocellular carcinoma (HCC), one of the most prevalent human cancers worldwide, remains unclear. Here, we examined the involvement of ITGB4 in HCC and explored the underlying mechanisms. Real-time PCR and immunohistochemical analyses of tissues from 82 patients with HCC and four HCC cell lines showed higher ITGB4 levels in tumor than in adjacent non-tumor tissues and in HCC than in normal hepatic cells. Silencing of ITGB4 repressed cell proliferation, colony forming ability and cell invasiveness, whereas ectopic expression of ITGB4 promoted the proliferation and invasion of HCC cells and induced epithelial to mesenchymal transition (EMT) in parallel with the upregulation of Slug, as shown by transwell assays, WB and immunocytochemistry. Knockdown of Slug reduced cell viability inhibited invasion and reversed the effects of ITBG4 overexpression on promoting EMT, and AKT/Sox2-Nanog may also be involved. In a xenograft tumor model induced by injection of ITGB4-overexpressing cells into nude mice, ITGB4 promoted tumor growth and metastasis to the lungs. Taken together, our results indicate that ITGB4 plays a tumorigenic and pro-metastatic role mediated by Slug and suggest IGTB4 could be a prognostic indicator or a therapeutic target in patients with HCC.